Literature DB >> 19772968

Categorizing neonatal deaths: a cross-cultural study in the United States, Canada, and The Netherlands.

A A Eduard Verhagen1, Annie Janvier, Steven R Leuthner, B Andrews, J Lagatta, Arend F Bos, William Meadow.   

Abstract

OBJECTIVE: To clarify the process of end-of-life decision-making in culturally different neonatal intensive care units (NICUs). STUDY
DESIGN: Review of medical files of newborns >22 weeks gestation who died in the delivery room (DR) or the NICU during 12 months in 4 NICUs (Chicago, Milwaukee, Montreal, and Groningen). We categorized deaths using a 2-by-2 matrix and determined whether mechanical ventilation was withdrawn/withheld and whether the child was dying despite ventilation or physiologically stable but extubated for neurological prognosis.
RESULTS: Most unstable patients in all units died in their parents' arms after mechanical ventilation was withdrawn. In Milwaukee, Montreal, and Groningen, 4% to 12% of patients died while receiving cardiopulmonary resuscitation. This proportion was higher in Chicago (31%). Elective extubation for quality-of-life reasons never occurred in Chicago and occurred in 19% to 35% of deaths in the other units. The proportion of DR deaths in Milwaukee, Montreal, and Groningen was 16% to 22%. No DR deaths occurred in Chicago.
CONCLUSIONS: Death in the NICU occurred differently within and between countries. Distinctive end-of-life decisions can be categorized separately by using a model with uniform definitions of withholding/withdrawing mechanical ventilation correlated with the patient's physiological condition. Cross-cultural comparison of end-of-life practice is feasible and important when comparing NICU outcomes.

Entities:  

Mesh:

Year:  2010        PMID: 19772968     DOI: 10.1016/j.jpeds.2009.07.019

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  32 in total

1.  Characterization of Death in Neonatal Encephalopathy in the Hypothermia Era.

Authors:  Monica E Lemmon; Renee D Boss; Sonia L Bonifacio; Audrey Foster-Barber; A James Barkovich; Hannah C Glass
Journal:  J Child Neurol       Date:  2016-12-20       Impact factor: 1.987

2.  Characteristics of childbearing women, obstetrical interventions and preterm delivery: a comparison of the US and France.

Authors:  Jennifer Zeitlin; Béatrice Blondel; Cande V Ananth
Journal:  Matern Child Health J       Date:  2015-05

3.  Does diagnosis influence end-of-life decisions in the neonatal intensive care unit?

Authors:  J Weiner; J Sharma; J Lantos; H Kilbride
Journal:  J Perinatol       Date:  2014-09-18       Impact factor: 2.521

Review 4.  Survival of Infants Born at Periviable Gestational Ages.

Authors:  Ravi Mangal Patel; Matthew A Rysavy; Edward F Bell; Jon E Tyson
Journal:  Clin Perinatol       Date:  2017-03-22       Impact factor: 3.430

Review 5.  Knowing when to stop: futility in the ICU.

Authors:  Dominic J C Wilkinson; Julian Savulescu
Journal:  Curr Opin Anaesthesiol       Date:  2011-04       Impact factor: 2.706

Review 6.  Palliative care in neonatal neurology: robust support for infants, families and clinicians.

Authors:  M E Lemmon; M Bidegain; R D Boss
Journal:  J Perinatol       Date:  2015-12-10       Impact factor: 2.521

7.  Medical record documentation and symptom management at the end of life in the NICU.

Authors:  Christine A Fortney; Deborah K Steward
Journal:  Adv Neonatal Care       Date:  2015-02       Impact factor: 1.968

8.  A new framework to evaluate the quality of a neonatal death.

Authors:  Christine A Fortney; Deborah K Steward
Journal:  Death Stud       Date:  2013-09-02

9.  Mode of neonatal death in an Irish maternity centre.

Authors:  Daragh Finn; Aedin Collins; Brendan P Murphy; Eugene M Dempsey
Journal:  Eur J Pediatr       Date:  2014-06-11       Impact factor: 3.183

10.  Integrating neurocritical care approaches into neonatology: should all infants be treated equitably?

Authors:  P C Mann; S M Gospe; K J Steinman; B S Wilfond
Journal:  J Perinatol       Date:  2015-08-06       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.